Search Results - "Ogawa, Lauren"

Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease by Ogawa, Lauren, Lindquist, Deborah

“…Background: Continuous therapy targeting human epidermal growth factor receptor 2 (HER2) is recommended until disease progression for patients with…”
Get full text

Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications by Ogawa, Lauren, Beaird, Omer E., Schaenman, Joanna M.

“…Patients with a failing kidney allograft are often continued on immunosuppression (IS) to preserve residual kidney function and prevent allosensitization. It…”
Get full text

A CASE OF ACUTE KIDNEY INJURY ASSOCIATED WITH TRAMETANIB/DABRAFENIB by Ogawa, Lauren, Saxena, Nishkarsh

“…Background: BRAF inhibitor, dabrafenib, interrupts cell signaling and slows cell growth, providing a targeted treatment for 40-50% of melanoma cases with BRAF…”
Get full text

213. Prophylactic oral vancomycin for Clostridioides difficile in allogeneic hematopoietic stem cell transplant recipients by Ogawa, Lauren, Wright, Kaylor, Luk, Alfred

“…Abstract Background Allogeneic hematopoietic stem cell transplant (alloHSCT) recipients are at substantial risk for Clostridioides difficile infection (CDI)…”
Get full text

Treponema and Bartonella Coinfection in a Human Immunodeficiency Virus–Positive Individual by Ogawa, Lauren, Alasady, Hussein, Terriquez, Joel

“…ABSTRACTInfection with human immunodeficiency virus (HIV) leads to an acquired immunocompromised state, allowing for the rise of opportunistic infections. Here…”
Get full text

Risk Factors and Outcomes of Mucorales Infection in a Modern Cohort of Solid Organ Transplant, Hematopoietic Cell Transplant, and Chimeric Antigen Receptor T-cell Therapy Recipients by Ogawa, Lauren, Multani, Ashrit, Beaird, Omer E., Gaynor, Pryce, Carlson, Margrit, Garner, Omai B., Schiller, Gary, Schaenman, Joanna M.

“…Mucorales infections continue to cause significant morbidity and mortality in immunocompromised hosts despite the advent of new approaches for diagnosis and…”
Get full text

Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery by Applewhite, Megan K., White, Michael G., Xiong, Maggie, Pasternak, Jesse D., Abdulrasool, Layth, Ogawa, Lauren, Suh, Insoo, Gosnell, Jessica E., Kaplan, Edwin L., Duh, Quan-Yang, Angelos, Peter, Shen, Wen T., Grogan, Raymon H.

“…Background The reported rate of incidental parathyroidectomy (IP) during thyroid surgery is between 5.2 and 21.6 %. Current literature reports wide discrepancy…”
Get full text

Central neck lymph node dissection for papillary thyroid cancer: The reliability of surgeon judgment in predicting which patients will benefit by Shen, Wen T., MD, MA, Ogawa, Lauren, Ruan, Daniel, MD, Suh, Insoo, MD, Duh, Quan-Yang, MD, Clark, Orlo H., MD

“…Background The role of routine prophylactic central-neck lymph node dissection (CLND) for papillary thyroid cancer (PTC) remains controversial. We perform CLND…”
Get full text

Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations by Shen, Wen T, Ogawa, Lauren, Ruan, Daniel, Suh, Insoo, Kebebew, Electron, Duh, Quan-Yang, Clark, Orlo H

“…The American Thyroid Association recently changed its management guidelines for papillary thyroid cancer (PTC) to include routine central neck lymph node…”
Get more information

Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease by Ogawa, Lauren, Lindquist, Deborah

“…BACKGROUNDContinuous therapy targeting human epidermal growth factor receptor 2 (HER2) is recommended until disease progression for patients with…”
Get full text